PharmEnable supports early drug discovery programs by providing a rapid, cost efficient, and effective platform to identify new hit candidates. They use their unique and diverse virtual compound library in conjunction with our computational screening programs, to identify novel active chemical starting points against the most challenging biological targets
Status | Active |
Website | http://www.pharmenable.com/ |
Category | Pharmaceutical Enabler |
Modality | Digital & Small Molecule |
Headquaters | Cambridge, UK |
Partner | Precision Life |
Investment Portfolio | Fund Investment |
Co-Investors | Cambridge Enterprise, Meltwind |